Long-Term Treatment of Osteopetrosis with Recombinant Human Interferon Gamma
Authors:
- L. Lyndon Jr. KeyLKL. Lyndon Jr. Key
- Ramona Marie RodriguizRRRamona Marie Rodriguiz
- Steven M. WilliSWSteven M. Willi
- Nancy M. WrightNWNancy M. Wright
- Heather C. HatcherHHHeather C. Hatcher
- David R. EyreDEDavid R. Eyre
- Joel K. CureJCJoel K. Cure
- Paul P. GriffinPGPaul P. Griffin
- William L. RiesWRWilliam L. Ries
Open Access
- 15 June 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (24) , 1594-1599
Abstract
Congenital osteopetrosis is a rare osteosclerotic bone disease characterized by both a defect in osteoclastic function and reduced generation of superoxide by leukocytes. The disease is frequently fatal during the first decade of life. A six-month trial of therapy with recombinant human interferon gamma-1b in eight patients with osteopetrosis provided evidence of benefit, prompting this study of more prolonged therapy.Keywords
This publication has 18 references indexed in Scilit:
- Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopeniaEndocrinology, 1994
- Superoxide and bone resorptionBone, 1994
- Combination Macrophage-Colony Stimulating Factor and Interferon-γ Administration Ameliorates the Osteopetrotic Condition in Microphthalmic (mi/mi) MicePediatric Research, 1993
- Nitroblue tetrazolium reduction and bone resorption by osteoclasts in vitro inhibited by a manganese-based superoxide dismutase mimicJournal of Bone and Mineral Research, 1992
- Recombinant human interferon gamma therapy for osteopetrosisThe Journal of Pediatrics, 1992
- Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.Journal of Clinical Investigation, 1990
- Oxygen derived free radicals in osteoclasts: The specificity and location of the nitroblue tetrazolium reactionBone, 1990
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gammaJournal of Bone and Mineral Research, 1986
- Treatment of Congenital Osteopetrosis with High-Dose CalcitriolNew England Journal of Medicine, 1984